Article Name Medical Diagnostic

BD receive US FDA approval for Onclarity HPV assay

HPV primary testing without the need for a traditional Pap smear performed with a speculum...Read more

15th May, 2024


BM Birla Heart Hospital spearheads ‘Enhanced Cardiac Care’ programme with Dozee

Focusing on continuous monitoring to identify and address clinical deterioration early...Read more

13th May, 2024


Fujifilm unveils Lung Navigation - Synapse 3D technology in Kochi

Synapse 3D is equipped with specialised technology which identifies three optimal paths leading to a lung lesion...Read more

13th May, 2024


Beurer India to touch Rs 500 Cr in next 3 years

Beurer India unveils cricket legend Sourav Ganguly as its new Brand Ambassador...Read more

10th May, 2024


Government of India launches Meditech Stackathon 2024

Industry captains and key stakeholders to brainstorm on the Value Chain Mapping of the select medical devices...Read more

07th May, 2024


Inocras, AstraZeneca strengthen genetic testing services in Hong Kong and Macau

For eligible patients diagnosed with breast, ovarian, prostate and pancreatic cancer...Read more

07th May, 2024


Beckman Coulter and MeMed extend partnership advancing host immune response diagnostics

Beckman Coulter now an authorised distributor of MeMed key immunoassay system and MeMed BV assay...Read more

07th May, 2024


GE HealthCare launches new SIGNA MAGNUS MR scanner to expand neuroscience field

A high-performance head-only MR scanner in comparison to conventional whole-body MR systems known so far...Read more

05th May, 2024


How to Enhance the Acceptance of Versatile CRISPR Diagnostics

CRISPR/Cas system, a popular gene editing system known for its targeted genomic cleaving capabilities, is being widely used for the development of gene edited therapies. Since 2016, CRISPR/Cas has also been extensively u...Read more

01st May, 2024 | By Ruplekha Choudhurie, Team Lead (Health & Wellness), TechVision, Frost & Sullivan; and Neeraja Vettekudath, Research Analyst, TechVision, Frost & Sullivan 


Owlstone Medical secures $6.5 M to develop breath-based diagnostics for infectious disease

Developing new cost-effective detection technologies for volatile organic compounds (VOCs)...Read more

25th April, 2024


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer